At Adare, we have the ability to add valuable IP to commercialized products and products in development.
Our extensive patent portfolio includes more than 345 granted patents and 166 pending patent applications. This portfolio is composed of patents with claims directed to our technologies and related materials, processes, and methods of manufacturing. We also have many product-related patents that contain more specific claims directed to particular drugs or classes of drugs.
Whether you are creating new products or have a life-cycle management goal, Adare can generate IP to help protect your products from the competition and maximize your commercial opportunity.